VBI Vaccines Inc/BC financial data

Symbol
VBIVQ on OTC
Location
160 Second Street, Cambridge, Cambridge, MA
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
SciVac Therapeutics Inc. (to 6/13/2016), LEVON RESOURCES LTD. (to 7/17/2015), LEVON RESOURCES LTD (to 9/7/2010)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 56 % -75.1%
Quick Ratio 12.7 % -22.3%
Return On Equity -1.08K % -574%
Return On Assets -94.4 % -23.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.4M shares -89%
Common Stock, Shares, Outstanding 25.2M shares +193%
Entity Public Float 22M USD -85.8%
Common Stock, Value, Issued 455M USD +2.88%
Weighted Average Number of Shares Outstanding, Basic 24.6M shares +186%
Weighted Average Number of Shares Outstanding, Diluted 24.6M shares +186%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.41M USD +553%
Research and Development Expense 8.76M USD -46.2%
General and Administrative Expense 52.8M USD +60.2%
Operating Income (Loss) -72.2M USD +15.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -83M USD +30.7%
Net Income (Loss) Attributable to Parent -83M USD +30.7%
Earnings Per Share, Basic -3.54 USD/shares -197%
Earnings Per Share, Diluted -3.54 USD/shares +77.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 101M USD -6.37%
Accounts Receivable, after Allowance for Credit Loss, Current 227K USD -19.2%
Inventory, Net 9.94M USD +46.9%
Other Assets, Current 1.99M USD +0.91%
Assets, Current 26.4M USD -49.1%
Property, Plant and Equipment, Net 9.09M USD -22.3%
Operating Lease, Right-of-Use Asset 1.95M USD -34.9%
Intangible Assets, Net (Excluding Goodwill) 35.7M USD -38.9%
Goodwill 1.11M USD -48.1%
Other Assets, Noncurrent 1.21M USD -8.01%
Assets 75.4M USD -41.3%
Accounts Payable, Current 8.87M USD -9.82%
Employee-related Liabilities, Current 1.97M USD -22.1%
Contract with Customer, Liability, Current 9.62M USD +1382%
Liabilities, Current 77.6M USD +162%
Contract with Customer, Liability, Noncurrent 1.61M USD -18%
Operating Lease, Liability, Noncurrent 1.14M USD -43.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 31.8M USD +13.5%
Retained Earnings (Accumulated Deficit) -600M USD -16%
Stockholders' Equity Attributable to Parent -5.47M USD -112%
Liabilities and Equity 75.4M USD -41.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.8M USD +45.7%
Net Cash Provided by (Used in) Financing Activities 843K USD
Net Cash Provided by (Used in) Investing Activities -151K USD +71.7%
Common Stock, Shares, Issued 25.2M shares +193%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.1M USD +50.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.57M USD +8.91%
Deferred Tax Assets, Valuation Allowance 117M USD +18.4%
Deferred Tax Assets, Gross 117M USD +18.4%
Operating Lease, Liability 1.97M USD -34.7%
Payments to Acquire Property, Plant, and Equipment 151K USD -71.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -79.2M USD +16.9%
Lessee, Operating Lease, Liability, to be Paid 2.24M USD -37.8%
Property, Plant and Equipment, Gross 20.1M USD -0.9%
Operating Lease, Liability, Current 831K USD -15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 584K USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 663K USD -44.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -7.69%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276K USD -53.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 160K USD -73.1%
Deferred Tax Assets, Operating Loss Carryforwards 109M USD +10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 163K USD -73.7%
Operating Lease, Payments 341K USD +26.8%
Additional Paid in Capital 87.7M USD +10.9%
Depreciation, Depletion and Amortization 493K USD -2.95%
Interest Expense 6.79M USD +51%